Online Impact
Statistics from Altmetric.com
ARTICLE USAGE
Cited By
Article Information
Volume 18, Issue 3, pp. 602-612
PubMed
Published By
Print ISSN
Online ISSN
History
- Received July 26, 2018
- Revision received October 26, 2018
- Accepted January 10, 2019
- Published first January 15, 2019.
Article Versions
- Previous version (January 15, 2019 - 07:40).
- You are viewing the most recent version of this article.
Copyright & Usage
©2019 American Association for Cancer Research.
Author Information
- Takeshi Harada1,
- Shinji Matsumoto1,
- Suguru Hirota1,
- Hirokazu Kimura1,
- Shinsuke Fujii1,
- Yuuya Kasahara2,3,
- Hidetoshi Gon4,
- Toshihiko Yoshida4,
- Tomoo Itoh5,
- Naotsugu Haraguchi6,
- Tsunekazu Mizushima6,
- Takehiro Noda6,
- Hidetoshi Eguchi6,
- Satoshi Nojima7,
- Eiichi Morii7,
- Takumi Fukumoto4,
- Satoshi Obika2,3, and
- Akira Kikuchi1,*
- 1Department of Molecular Biology and Biochemistry, Graduate School of Medicine, Osaka University, Osaka, Japan.
- 2Graduate School of Pharmaceutical Sciences, Osaka University, Osaka, Japan.
- 3National Institutes of Biomedical Innovation, Health and Nutrition, Osaka, Japan.
- 4Division of Hepato-Biliary-Pancreatic Surgery, Department of Surgery, Kobe University Graduate School of Medicine, Kobe, Hyogo, Japan.
- 5Division of Diagnostic Pathology, Kobe University Graduate School of Medicine, Kobe, Hyogo, Japan.
- 6Department of Gastroenterological Surgery, Graduate School of Medicine, Osaka University, Osaka, Japan.
- 7Department of Pathology, Graduate School of Medicine, Osaka University, Osaka, Japan.
- ↵*Corresponding Author:
Akira Kikuchi, Graduate School of Medicine, Osaka University, 2-2, Yamadaoka, Suita, Osaka 565-0871, Japan. Phone: 81-6-6879-3410; Fax: 81-6-6879-3419; E-mail: akikuchi{at}molbiobc.med.osaka-u.ac.jp
March 2019
Volume 18, Issue 3
Volume 18, Issue 3
Chemically Modified Antisense Oligonucleotide Against ARL4C Inhibits Primary and Metastatic Liver Tumor Growth
Jump to section
Advertisement